Searched for
VYOME THERAPEUTICS
Navam Capital makes final close of maiden fund at Rs 315 croreNavam Capital has closed its maiden fund, Navam Venture Fund-I, at over Rs 315 crore ($35 million), surpassing its original target of Rs 25...- Tata 1mg’s FY24 report; Cognizant-Wipro CFO lawsuit settledEpharmacy Tata 1mg reported a 21% rise in revenue to Rs 1,968 crore for FY24. This and more on today’s ETtech Top 5.
- Biotech firm Vyome Therapeutics to go public via reverse merger with Nasdaq-listed Reshape LifesciencesVyome Therapeutics, a biotech company backed by Manipal group chief Ranjan Pai, will go public in the US through a reverse merger with US-b...
- Mubadala, Brunei’s Sovereign Wealth Fund look to pick up a slice of Manipal HospitalsTemasek owned Sheares Health, is in advanced negotiations to sell 8-9% of its 59% interest in Manipal Health Enterprises to Abu Dhabi' fund...
- Biopharma Co Vyome gets Rs 154 crore from investorsExisting investors Perceptive Advisors, Romulus Capital and Kalaari Capital also participated in this round.
- Vyome Biosciences closes $8 million funding roundProceeds from the Series B round of funding will be used to drive the completion of critical milestones of US Food and Drug Administration ...
- Startups do promising work in drug development, stem cell therapy and advanced diagnosticsDemand for quality healthcare and easier access to capital have led to the launch of many startups working in such areas as new drug develo...
- NRI scientists who turned research into successful businessesNot many Indians in US would risk turning their scientific research into successful businesses. Here is the story of the bravehearts who di...
Load More